Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
7.71
-0.57 (-6.88%)
At close: Oct 8, 2025, 4:00 PM EDT
7.71
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:57 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $4.78 million as of October 8, 2025. Its market cap has increased by 12.61% in one year.
Market Cap
4.78M
Enterprise Value
-66.61K
1-Year Change
12.61%
Ranking
Category
Stock Price
$7.71
Market Cap Chart
Since October 28, 2016, Biodexa Pharmaceuticals's market cap has decreased from $55.80M to $4.78M, a decrease of -91.44%. That is a compound annual growth rate of -24.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 5.13M | 118.06% |
| Dec 31, 2024 | 2.35M | -66.49% |
| Dec 29, 2023 | 7.02M | 64.98% |
| Dec 30, 2022 | 4.26M | -67.32% |
| Dec 31, 2021 | 13.02M | -43.85% |
| Dec 31, 2020 | 23.19M | 52.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.66B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.81B |